Literature DB >> 10534191

Lack of induction by rhinoviruses of systemic type I interferon production or enhanced MxA protein expression during the common cold.

M J Mäkelä1, M Halminen, O Ruuskanen, T Puhakka, J Pirhonen, I Julkunen, J Ilonen.   

Abstract

To study whether MxA protein expression is systemically upregulated during rhinovirus infection, blood specimens were collected from 40 patients with common cold and MxA expression in mononuclear cells analyzed by flow cytometry. None of the patients with a confirmed rhinovirus infection (n = 15) or with an infection of unknown etiology (n = 20) had elevated expression of the MxA protein (median fluorescence intensity, 549 and 582, respectively) when compared to healthy controls (n = 11, median 590). Patients with influenza infections had significantly elevated values (n = 5, median 750), and interferon could be detected only in serum samples from influenza patients. In conclusion, expression of MxA in blood lymphocytes and an apparently systemic type I interferon response is not induced during rhinovirus infection or during most other cases of common cold in young adult patients.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10534191      PMCID: PMC7088351          DOI: 10.1007/s100960050370

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  7 in total

Review 1.  Innate and adaptive immune responses against picornaviruses and their counteractions: An overview.

Authors:  Andreas Dotzauer; Leena Kraemer
Journal:  World J Virol       Date:  2012-06-12

2.  Receptor characterization and susceptibility of cotton rats to avian and 2009 pandemic influenza virus strains.

Authors:  Jorge C G Blanco; Lioubov M Pletneva; Hongquan Wan; Yonas Araya; Matthew Angel; Raymonde O Oue; Troy C Sutton; Daniel R Perez
Journal:  J Virol       Date:  2012-11-28       Impact factor: 5.103

3.  Pathways activated during human asthma exacerbation as revealed by gene expression patterns in blood.

Authors:  Unnur S Bjornsdottir; Stephen T Holgate; Padmalatha S Reddy; Andrew A Hill; Charlotte M McKee; Cristina I Csimma; Amy A Weaver; Holly M Legault; Clayton G Small; Renee C Ramsey; Debra K Ellis; Conor M Burke; Philip J Thompson; Peter H Howarth; Andrew J Wardlaw; Phillip G Bardin; David I Bernstein; Louis B Irving; Geoffrey L Chupp; George W Bensch; Gregory W Bensch; Jon E Stahlman; Monroe Karetzky; James W Baker; Rachel L Miller; Brad H Goodman; Donald G Raible; Samuel J Goldman; Douglas K Miller; John L Ryan; Andrew J Dorner; Frederick W Immermann; Margot O'Toole
Journal:  PLoS One       Date:  2011-07-14       Impact factor: 3.240

4.  PROPHYLACTIC ANTIBODY TREATMENT AND INTRAMUSCULAR IMMUNIZATION REDUCE INFECTIOUS HUMAN RHINOVIRUS 16 LOAD IN THE LOWER RESPIRATORY TRACT OF CHALLENGED COTTON RATS.

Authors:  Jorge C G Blanco; Susan Core; Lioubov M Pletneva; Thomas H March; Marina S Boukhvalova; Adriana E Kajon
Journal:  Trials Vaccinol       Date:  2014

5.  Blood MxA protein as a marker for respiratory virus infections in young children.

Authors:  Laura Toivonen; Linnea Schuez-Havupalo; Maris Rulli; Jorma Ilonen; Jukka Pelkonen; Krister Melen; Ilkka Julkunen; Ville Peltola; Matti Waris
Journal:  J Clin Virol       Date:  2014-11-18       Impact factor: 3.168

Review 6.  Mechanisms of virus-induced asthma exacerbations: state-of-the-art. A GA2LEN and InterAirways document.

Authors:  N G Papadopoulos; P Xepapadaki; P Mallia; G Brusselle; J-B Watelet; M Xatzipsalti; G Foteinos; C M van Drunen; W J Fokkens; C D'Ambrosio; S Bonini; A Bossios; Jan Lötvall; P van Cauwenberge; S T Holgate; G W Canonica; A Szczeklik; G Rohde; J Kimpen; A Pitkäranta; M Mäkelä; P Chanez; J Ring; S L Johnston
Journal:  Allergy       Date:  2007-02-27       Impact factor: 13.146

7.  Evaluation of a combined MxA and CRP point-of-care immunoassay to identify viral and/or bacterial immune response in patients with acute febrile respiratory infection.

Authors:  Robert Sambursky; Nathan Shapiro
Journal:  Eur Clin Respir J       Date:  2015-12-10
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.